IV
Illumina Ventures
Venture CapitalActiveIllumina Ventures visions is to improve human health by unlocking the power of the genome.
32
Investments
7
Exits
$1B
AUM
21.9%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Illumina Ventures.
Investment Thesis & Strategy
Illumina Ventures invests in various stages of companies within the genomics and life sciences sectors, seeking to improve human health by leveraging the power of the genome.
Investment Activity
Deals per year over the last 4 years
1
20206
20212
20223
2023Portfolio Companies
Selected investments from their portfolio of 32 companies
C
Convergent Genomics
Biotech · Series A, 2023
N
NodTherapeutics
Biotech · Series A, 2023
E
Element Biosciences
Biotech · Series C+, 2023
N
Nabla Bio
Biotech · Seed, 2022
E
Enveda Biosciences
Biotech · Series A, 2022
D
Deepcell
Biotech · Series A, 2021
G
GenEdit
Biotech · Series A, 2021
L
Loop Genomics
Biotech · Series A, 2021
H
Hayward Holdings
Healthcare · Growth, 2021
T
Tessera Therapeutics
Biotech · Series B, 2021
E
Element Biosciences
Biotech · Series B, 2021
S
Singular Genomics
Biotech · Series B, 2020
Notable Exits
CompanyTypeYearValue / Acquirer
Mission BioAcquisition2024—
Element BiosciencesAcquisition2024—
Singular GenomicsIPO2022$1.5B
Loop GenomicsAcquisition2022—
Basecamp ResearchAcquisition2021—
Hayward HoldingsIPO2021$2.4B
GenalyteAcquisition2021—
Frequently Asked Questions
Illumina Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Scale Venture Partners
Foster City, United States · 234 deals
Geodesic Capital
Foster City, United States · 32 deals
BA Venture Partners
Foster City, United States · 11 deals
Visa International Service Association
Foster City, United States · 8 deals
Bessemer Venture Partners
Redwood City, United States · 971 deals
Threshold
Menlo Park, United States · 841 deals